176 related articles for article (PubMed ID: 30210010)
61. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
Baek JS; Pham CV; Myung CS; Cho CW
Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
[TBL] [Abstract][Full Text] [Related]
62. Design and Optimization of Febuxostat-loaded Nano Lipid Carriers Using Full Factorial Design.
Bhatt S; Sharma JB; Kamboj R; Kumar M; Saini V; Mandge S
Turk J Pharm Sci; 2021 Feb; 18(1):61-67. PubMed ID: 33633486
[TBL] [Abstract][Full Text] [Related]
63. Investigation of ethyl cellulose microsponge gel for topical delivery of eberconazole nitrate for fungal therapy.
Bothiraja C; Gholap AD; Shaikh KS; Pawar AP
Ther Deliv; 2014 Jul; 5(7):781-94. PubMed ID: 25287385
[TBL] [Abstract][Full Text] [Related]
64. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
[TBL] [Abstract][Full Text] [Related]
65. Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and
Mousavi-Simakani SM; Azadi A; Tanideh N; Omidifar N; Ghasemiyeh P; Mohammadi-Samani S
Adv Pharm Bull; 2023 Nov; 13(4):761-771. PubMed ID: 38022815
[TBL] [Abstract][Full Text] [Related]
66. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
[TBL] [Abstract][Full Text] [Related]
67. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
68. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study.
Arora R; Katiyar SS; Kushwah V; Jain S
Expert Opin Drug Deliv; 2017 Feb; 14(2):165-177. PubMed ID: 27882780
[TBL] [Abstract][Full Text] [Related]
69. Development of MART for the Rapid Production of Nanostructured Lipid Carriers Loaded with All-Trans Retinoic Acid for Dermal Delivery.
Ghate VM; Kodoth AK; Raja S; Vishalakshi B; Lewis SA
AAPS PharmSciTech; 2019 Apr; 20(4):162. PubMed ID: 30989451
[TBL] [Abstract][Full Text] [Related]
70. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
71. Development and characterization of spray dried microparticles for pulmonary delivery of antifungal drug.
Mathpal D; Garg T; Rath G; Goyal AK
Curr Drug Deliv; 2015; 12(4):464-71. PubMed ID: 25808185
[TBL] [Abstract][Full Text] [Related]
72. Oleic acid-loaded nanostructured lipid carrier inhibit neutrophil activities in the presence of albumin and alleviates skin inflammation.
Chen CY; Lee YH; Chang SH; Tsai YF; Fang JY; Hwang TL
Int J Nanomedicine; 2019; 14():6539-6553. PubMed ID: 31496699
[TBL] [Abstract][Full Text] [Related]
73. Luliconazole vesicular based gel formulations for its enhanced topical delivery.
Kaur M; Singh K; Jain SK
J Liposome Res; 2020 Dec; 30(4):388-406. PubMed ID: 31631734
[TBL] [Abstract][Full Text] [Related]
74. Nanostructured lipid carriers of pioglitazone for transdermal application: from experimental design to bioactivity detail.
Alam S; Aslam M; Khan A; Imam SS; Aqil M; Sultana Y; Ali A
Drug Deliv; 2016; 23(2):601-9. PubMed ID: 24937378
[TBL] [Abstract][Full Text] [Related]
75. Optimization and characterization of sertaconazole nitrate flexisomes embedded in hydrogel for improved antifungal activity.
Mandlik SK; Siras SS; Birajdar KR
J Liposome Res; 2019 Mar; 29(1):10-20. PubMed ID: 29160732
[TBL] [Abstract][Full Text] [Related]
76. Permeation of topically applied caffeine from a food by-product in cosmetic formulations: Is nanoscale in vitro approach an option?
Rodrigues F; Alves AC; Nunes C; Sarmento B; Amaral MH; Reis S; Oliveira MB
Int J Pharm; 2016 Nov; 513(1-2):496-503. PubMed ID: 27662805
[TBL] [Abstract][Full Text] [Related]
77. Development and Optimization of Imiquimod-Loaded Nanostructured Lipid Carriers Using a Hybrid Design of Experiments Approach.
Kim S; Abdella S; Abid F; Afinjuomo F; Youssef SH; Holmes A; Song Y; Vaidya S; Garg S
Int J Nanomedicine; 2023; 18():1007-1029. PubMed ID: 36855538
[TBL] [Abstract][Full Text] [Related]
78. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
79. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
[TBL] [Abstract][Full Text] [Related]
80. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis.
Gupta M; Vyas SP
Chem Phys Lipids; 2012 May; 165(4):454-61. PubMed ID: 22309657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
